DE60305592D1 - Liposomenhaltiges Mittel zur Behandlung Gefässerkrankungen - Google Patents

Liposomenhaltiges Mittel zur Behandlung Gefässerkrankungen

Info

Publication number
DE60305592D1
DE60305592D1 DE60305592T DE60305592T DE60305592D1 DE 60305592 D1 DE60305592 D1 DE 60305592D1 DE 60305592 T DE60305592 T DE 60305592T DE 60305592 T DE60305592 T DE 60305592T DE 60305592 D1 DE60305592 D1 DE 60305592D1
Authority
DE
Germany
Prior art keywords
liposome
treatment
vascular diseases
containing agent
biological data
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60305592T
Other languages
English (en)
Other versions
DE60305592T2 (de
Inventor
Kazuhiro Aikawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujifilm Corp
Original Assignee
Fuji Photo Film Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fuji Photo Film Co Ltd filed Critical Fuji Photo Film Co Ltd
Publication of DE60305592D1 publication Critical patent/DE60305592D1/de
Application granted granted Critical
Publication of DE60305592T2 publication Critical patent/DE60305592T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
DE60305592T 2002-09-25 2003-09-25 Liposomenhaltiges Mittel zur Behandlung Gefässerkrankungen Expired - Lifetime DE60305592T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2002278287 2002-09-25
JP2002278287A JP2004115397A (ja) 2002-09-25 2002-09-25 血管疾患治療薬を含むリポソーム

Publications (2)

Publication Number Publication Date
DE60305592D1 true DE60305592D1 (de) 2006-07-06
DE60305592T2 DE60305592T2 (de) 2007-04-26

Family

ID=31973261

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60305592T Expired - Lifetime DE60305592T2 (de) 2002-09-25 2003-09-25 Liposomenhaltiges Mittel zur Behandlung Gefässerkrankungen

Country Status (5)

Country Link
US (1) US20040120999A1 (de)
EP (1) EP1402884B1 (de)
JP (1) JP2004115397A (de)
AT (1) ATE327736T1 (de)
DE (1) DE60305592T2 (de)

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BG40180A1 (en) * 1984-07-02 1986-11-14 Gbev Antihelminthic means and method for preparing the means
US6077529A (en) * 1988-05-06 2000-06-20 Schmidt; Karl Heinz Active ingredient system and method of manufacture thereof for transfer of lipophilic and amphiphilic components to target structures
US5043165A (en) * 1988-12-14 1991-08-27 Liposome Technology, Inc. Novel liposome composition for sustained release of steroidal drugs
US5088499A (en) * 1989-12-22 1992-02-18 Unger Evan C Liposomes as contrast agents for ultrasonic imaging and methods for preparing the same
US5387600A (en) * 1992-07-30 1995-02-07 Fuji Photo Film Co., Ltd. Treating arteriosclerosis using benzimidazole compositions
US5869462A (en) * 1992-09-10 1999-02-09 The Board Of Trustees Of The Leland Stanford Junior University Inhibition of proliferation of vascular smooth muscle cell
DE4330959A1 (de) * 1993-09-09 1995-03-16 Schering Ag Neue Benzimidazolderivate, Verfahren zu ihrer Herstellung und ihre pharmazeutische Verwendung
JP3721193B2 (ja) * 1994-02-04 2005-11-30 富士写真フイルム株式会社 ２−メルカプトベンゾイミダゾール誘導体及び該誘導体を含有する抗高脂血症剤又は抗動脈硬化症剤
US6139871A (en) * 1995-07-26 2000-10-31 The University Of British Columbia Liposome compositions and methods for the treatment of atherosclerosis
US5660855A (en) * 1995-02-10 1997-08-26 California Institute Of Technology Lipid constructs for targeting to vascular smooth muscle tissue
AU6369696A (en) * 1995-07-17 1997-02-18 Fuji Photo Film Co., Ltd. Benzimidazole compounds
EP0914094A4 (de) * 1996-03-28 2000-03-01 Univ Illinois Materialen und verfahren zur herstellung verbesserter liposomaler mittel
PE11499A1 (es) * 1997-05-16 1999-03-01 Procter & Gamble Tratamiento del hiv y cancer
ES2224299T3 (es) * 1998-02-23 2005-03-01 Cilag Ag International Dispersion liposomal de eritroyetina.
AU2001252603B2 (en) * 2000-04-28 2005-10-13 Fuji Photo Film Co., Ltd. Liposomes containing hydrophobic iodo compound
EP1330441A2 (de) * 2000-09-26 2003-07-30 The University of Arizona Foundation Benzimidazole und deren verwendung für die behandlung von krebs oder viralen infektionen
JP2004523565A (ja) * 2001-03-05 2004-08-05 トランス　テック　ファーマ，インコーポレイテッド 治療因子としてのベンゾイミダゾール誘導体
ATE375173T1 (de) * 2001-08-20 2007-10-15 Fujifilm Corp Hydrophobe iodverbindung enthaltendes liposom und dieses enthaltendes röntgenkontrastmittel

Also Published As

Publication number Publication date
EP1402884A1 (de) 2004-03-31
US20040120999A1 (en) 2004-06-24
ATE327736T1 (de) 2006-06-15
EP1402884B1 (de) 2006-05-31
DE60305592T2 (de) 2007-04-26
JP2004115397A (ja) 2004-04-15

Similar Documents

Publication Publication Date Title
DE60043587D1 (de) Mittel für erkrankungen assoziert mit knochensubstanzverlust
CY1110322T1 (el) Αναστολεις της her3 δραστικοτητας
DE60328476D1 (de) Medizinisches ballonsystem zur behandlung von adipositas
WO2004056307A3 (en) Disease treatment via antimicrobial peptide inhibitors
DE69940131D1 (de) Mittel zur Behandlung von Erkrankungen der Speiseröhre
PT1263504E (pt) Compostos com actividade 5-ht1a uteis para o tratamento de perturbacoes da retina externa
DE60137635D1 (de) Verwendung von allopurinol zur behandlung von bluthochdruck
ATE132757T1 (de) Pharmazeutische zubereitung zur behandlung verlängerter gerinnungszeit
DE50010284D1 (de) Arzneimittel zur behandlung von bluthochdruck
CY1106155T1 (el) Χρηση παραγωγων 3-βενζολοφαινυλοξικων οξεων για την αντιμετωπιση διαταραχων του αμφιβληστροειδους
WO2003048122A3 (en) Inhibitors of cytosolic phospholipase a2
DE60027209D1 (de) Arzneimittel enthaltend hydroxyapatite zur behandlung von knochengewebserkrankungen
AU7966100A (en) Herbicidally active pyridine sulfonyl urea derivatives
DE50211137D1 (de) Seitenkettenhalogenierte aminodicarbonsaurederivate als arzneimittel zur behandlung von herz-kreislauf-erkrankungen
ATE357912T1 (de) Intrakorporelle medikamente zur hoch- energetischen phototherapeutischen behandlung von krankheiten
ATE337005T1 (de) Nagellack enthaltend tazaroten und verwendung dessen zur behandlung und/oder zur prävention von psoriasis
CO5280202A1 (es) Metodos de tratamiento y metodos de rastreo de farmacos
DE50111407D1 (de) Mittel enthaltend n-chlortaurin sowie dessen verwendung zur behandlung von schleimhautpolypen
WO2004056768A3 (en) Use of substituted 2,5-diamidoindoles for the treatment of urological diseases
TW200505408A (en) Agent for preventing and/or treating tissue disruption-accompanied diseases
ATE252383T1 (de) Verwendung von 2-methyl-thiazolidin-2,4- dicarbonsäure und / oder ihrer physiologisch verträglichen salze zur herstellung eines medikaments zur behandlung von krebserkrankungen
NO20021410D0 (no) Forebygging og behandling av blodkoagulasjons-relaterte sykdommer
DE60305592D1 (de) Liposomenhaltiges Mittel zur Behandlung Gefässerkrankungen
NO20032411L (no) Anvendelse av substituerte 6-dimetylaminometyl-1-fenyl- cykloheksan-forbindelser for behandling av urininkontinens
DE602004029993D1 (de) Pharmazeutische zusammensetzung zur behandlung von drogenabhängigkeit

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: FUJIFILM CORP., TOKIO/TOKYO, JP